Abstract

Becoming a caregiver of child with Type 1 Diabetes (T1D) involves understanding, accepting, and managing the new medical condition that may cause sleep deprivation, depression, anxiety, self-neglection, and poorer quality of life. Related to family caregiver fatigue, parental mental well-being has been associated with less effective parenting and poorer disease management of those kids. Digital Health programs can offer psychoeducational support to caregivers during family daily life, complementing medical care. The present study aims to better understand the barriers/facilitators to the adoption of a digital health solution for adaptive self-management. The digital solution provides a personalized digital program that includes motivational messages, educational units, mental well-being activities, and coaching services. A cohort of 20 caregivers of children with type 1 diabetes was recruited at a large pediatric hospital in Spain. Demographic and health data were recorded at baseline. After joining the program for 1 month, a SUS (System Usability Scale) questionnaire and a semi-structured interview were administrated. Preliminary results showed that the digital solution is widely useful in obtaining a SUS score of 95’38 out of 100 (SD 7’95) and achieved positive engagement outcomes. In the interviews, caregivers expressed that the educational units reinforced disease self-management. Mental health data at baseline exposed a high percentage of caregivers with symptoms of depression (25%), anxiety (35%), and stress (30%). These results highlight the importance of caregivers’ emotional wellness and the digital health solution's potential to empower them to self-manage during the disease. A subsequent study clinical study will evaluate the clinical impact of the digital intervention on a larger cohort during 2023. Disclosure L.Fernandez-luque: Other Relationship; Adhera Health Inc. A.De arriba: Board Member; Merck KGaA, Speaker's Bureau; Novo Nordisk. E.Civitani: None. M.Pilar ferrer: None. T.García castellanos: None. J.López-guimet: None. S.Quer palomas: Employee; AdheraHealth Inc. Funding Novo Nordisk Pharma S.A. (Spain)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.